Circadian‐timed quick‐release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus

OBJECTIVE: Sympathetic nervous system (SNS) overactivity is a risk factor for insulin resistance and cardiovascular disease (CVD). We evaluated the impact of bromocriptine‐QR, a dopamine‐agonist antidiabetes medication, on elevated resting heart rate (RHR) (a marker of SNS overactivity in metabolic...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Endocrinol Diabetes Metab
Main Authors: Chamarthi, Bindu, Vinik, Aaron, Ezrokhi, Michael, Cincotta, Anthony H.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6947713/
https://ncbi.nlm.nih.gov/pubmed/31922028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.101
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker